The Alphabet-owned health company Verily is employing a range of digital health technologies to make it easier for diabetes patients to keep their blood sugar under control, according to Vivian Lee, MD, PhD, president of health platforms at Verily.
Dr. Lee, who was a keynote speaker at the Center for Connected Medicine’s Top of Mind 2019 Summit, told the story of “Steve from Georgia,” a type 2 diabetic enrolled in a program run by Verily.
[Top of Mind for Top Health Systems 2021 research report examines shifting innovation priorities in the COVID-19 era]
Steve’s blood glucose levels were too high until he enrolled in a virtual clinic program called Onduo, run by Verily and drug company Sanofi, that provided him with a continuous glucose monitor and companion smartphone app. With the app, patients take pictures of the meals they eat and artificial intelligence recognizes the food items.
“We use Google Vision AI, and just the way it sorts your photos and sorts cats and dogs, it recognizes your food. And in fact for a lot of patients I think that’s the funnest thing for them,” Dr. Lee said.